• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Apr 14.
doi: 10.1002/jmv.27018. Online ahead of print.
Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child


Nihal Ak?ay[SUP] 1 [/SUP], Mehmet Emin Meneto?lu[SUP] 1 [/SUP], Gonca Bekta?[SUP] 2 [/SUP], Esra ?evketo?lu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: The relation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and demyelinating Guillain Barre Syndrome (GBS) has been defined. We aim to report the clinical features of a child with axonal GBS associated with SARS-CoV-2.
Case: A 6-year-old male presented with symmetric ascending paralysis progressed over a 4-day course and 2-day of fever. He had bilateral lower and upper limb flaccid weakness of 1/5 with absent deep tendon reflexes. He had severe respiratory muscle weakness requiring invasive mechanical ventilation. On admission, SARS-CoV-2 returned as positive by real-time polymerase chain reaction on a nasopharyngeal swab. Cerebrospinal fluid analysis showed elevated protein without pleocytosis. He was diagnosed with GBS associated with SARS-CoV-2 infection. The nerve conduction study was suggestive of acute motor axonal neuropathy. Ten consecutive therapeutic plasma exchange sessions with 5% albumin replacement followed by four sessions on alternate days were performed. On day 12, methylprednisolone (30 mg/kg/day for 5 days) was given. On day 18, intravenous immunoglobulin (IVIG) (2 g/kg/day) was given and repeated 14 days after due to severe motor weakness. On day 60, he was discharged from the hospital with weakness of neck flexor and extensor muscles of 3/5 and the upper limbs and the lower limbs of 2/5 on home-ventilation.
Conclusion: Our patient is considered to be the youngest patient presenting with a possible para-infectious association between axonal GBS and SARS-CoV-2 infection. The disease course was severe with a rapid progression, an earlier peak, and prolonged duration in weakness as expected in axonal GBS This article is protected by copyright. All rights reserved.
 
Back
Top Bottom